The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 05, 2018
Filed:
Jan. 27, 2015
Applicant:
Theravectys, Paris, FR;
Inventors:
Deborah Revaud, Mondeville, FR;
Cecile Bauche, Paris, FR;
Assignee:
THERAVECTYS, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/21 (2006.01); A61K 39/12 (2006.01); C07K 14/05 (2006.01); C07K 14/15 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01); C12N 15/86 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C07K 14/15 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/53 (2013.01); C12N 2740/14022 (2013.01); C12N 2740/14034 (2013.01); C12N 2740/14071 (2013.01); C12N 2740/15023 (2013.01); C12N 2740/15034 (2013.01); C12N 2740/15043 (2013.01);
Abstract
The present invention relates to compositions, methods, and uses employing lentiviral vector particles for induction of an immune response by administration to a human, wherein the lentiviral vector particles comprise a lentiviral vector, wherein the DNA of the lentiviral vector comprises a promoter directing expression of a HTLV-1 p12p30-Tax-HBZ fusion protein. The invention encompasses these vectors, methods of making the vectors, and methods of using them, including medicinal uses.